Answers are grounded in this paper and cite their sources.
Anemia is one of the most common complications of inflammatory bowel disease (IBD), with estimates of its prevalence varying from 9-74%. It is estimated to affect more than 1.2 billion people worldwide and evidence suggests that the incidence of anemia in people with IBD is almost double that of people without IBD (92.75 people with IBD per 1000 person-years vs 51.18 without IBD per 1000 person-years). Having a thorough approach to anemia in IBD is important because it is common and potentially dangerous, and because of its potential to arise from multiple different pathological and/or physiological processes.
No takes yet. Share an insight, caveat, or question.
Chris Sheasgreen (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: